Singapore, 1 April 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components specialist, announced today that its subsidiary ABio, in collaboration with Neoregen Biotech, is […]
Tag: ABIO
CDW Holding’s Subsidiary ABio Signs Joint R&D Agreement with Neoregen Biotech to Advance Next-Generation Lipid Nanoparticle Technology
Singapore, 20 January 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components and life sciences specialist, today announced that its subsidiary, A Biotech, has signed […]
CDW Holding Announces Breakthroughs in Cancer-Targeting Antibody Research
Singapore, November 13, 2024 – CDW Holding Limited, a SGX Mainboard-listed company headquartered in Hong Kong, today announced significant progress in its biotechnology subsidiary’s antibody […]